Price to Book AnalysisPrice to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is accounting value of assets minus liabilities.
About Price to BookPrice to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
|Compare to competition|
Based on latest financial disclosure the price to book indicator of Virtus LifeSci Biotech Clinical Trls ETF is roughly 1.75 times. This is much higher than that of the BioShares family, and significantly higher than that of Sector category, The Price to Book for all etfs is over 1000% lower than the firm.
Virtus LifeSci Biotech Fundamental Drivers Relationships0.05 of Price to Sales per Price to Earning. The ratio of Price to Earning to Price to Sales for Virtus LifeSci Biotech Clinical Trls ETF is roughly 20.04
The fund invests 99.71% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.